
    
      Breast cancer is the most common malignant tumor in female wolrdwide. Results from clinical
      trials like ATAC trial have demonstrated the efficacy of AIs in postmenopausal breast cancer
      patients. Meanwhile it may cause a certain rate of osteoporosis in postmenopausal patients.
      The aim of this trial is to test the efficacy of two traditional Chinese medicine in
      preventing osteoporosis in patients receiving adjuvant endocrine therapy.
    
  